MicroRNA related polymorphisms and breast cancer risk

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Khan, Sofia ^a   Greco, Dario ^a,b   Michailidou, Kyriaki ^c   Milne, Roger L ^d,e   Muranen, Taru A ^a   Heikkinen, Tuomas ^a   Aaltonen, Kirsimari ^a,f   Dennis, Joe ^c   Bolla, Manjeet K ^c   Liu, Jianjun ^g   Hall, Per ^h   Irwanto, Astrid ^g   Humphreys, Keith ^h   Li, Jingmei ^g   Czene, Kamila ^h   Chang Claude, Jenny ⁱ   Hein, Rebecca ^i,j   Rudolph, Anja ⁱ   Seibold, Petra ⁱ   Flesch Janys, Dieter ^k   Fletcher, Olivia ^cf   Peto, Julian ^cf   Silva, Isabel Dos Santos ^l,m   Johnson, Nichola ^cf   Gibson, Lorna ^cf   Aitken, Zoe ^l,m   Hopper, John L ⁿ   Tsimiklis, Helen ^o   Bui, Minh ^e   Makalic, Enes ^e   Schmidt, Daniel F ^e   Southey, Melissa C ⁿ   Apicella, Carmel ^e   Stone, Jennifer ^e   Waisfisz, Quinten ^o   Meijers Heijboer, Hanne ^o   Adank, Muriel A ^o   Van Der Luijt, Rob B ^p   Meindl, Alfons ^q   Schmutzler, Rita K ^j,r   Müller Myhsok, Bertram ^s   Lichtner, Peter ^s   Turnbull, Clare ^t   Rahman, Nazneen ^l   Chanock, Stephen J ^u   Hunter, David J ^v   Cox, Angela ^w   Cross, Simon S ^w   Reed, Malcolm W R ^w   Schmidt, Marjanka K ^x   Broeks, Annegien ^x   Van'T Veer, Laura J ^x   Hogervorst, Frans B ^x   Fasching, Peter A ^y,z   Schrauder, Michael G ^y   Ekici, Arif B ^aa   Beckmann, Matthias W ^cf   Bojesen, Stig E ^cf   Nordestgaard, Børge G ^cf   Nielsen, Sune F ^cf   Flyger, Henrik ^cf   Benitez, Javier ^cf   Zamora, Pilar M ^cf   Perez, Jose I A ^cf   Haiman, Christopher A ^cf   Henderson, Brian E ^cf   Schumacher, Fredrick ^cf   March, Loic Le ^cf   Pharoah, Paul D P ^cf   Dunning, Alison M ^cf   Shah, Mitul ^cf   Luben, Robert ^cf   Brown, Judith ^cf   Couch, Fergus J ^cf   Wang, Xianshu ^cf   Vachon, Celine ^cf   Olson, Janet E ^cf   Lambrechts, Diether ^cf   Moisse, Matthieu ^cf   Paridaens, Robert ^cf   Christiaens, Marie Rose ^cf   Guénel, Pascal ^cf   Truong, Thérèse ^cf   Laurent Puig, Pierre ^cf   Mulot, Claire ^cf   Marme, Frederick ^cf   Burwinkel, Barbara ^cf   Schneeweiss, Andreas ^cf   Sohn, Christof ^cf   Sawyer, Elinor J ^cf   Tomlinson, Ian ^cf   Kerin, Michael J ^cf   Miller, Nicola ^cf   Andrulis, Irene L ^cf   Knight, Julia A ^cf   Tchatchou, Srine ^cf   Mulligan, Anna Marie ^cf   Dörk, Thilo ^cf   Bogdanova, Natalia V ^cf   Antonenkova, Natalia N ^cf   Anton Culver, Hoda ^cf   Darabi, Hatef ^cf   Eriksson, Mikael ^cf   Garcia Closas, Montserrat ^cf   Figueroa, Jonine ^cf   Lissowska, Jolanta ^cf   Brinton, Louise ^cf   Devilee, Peter ^cf   Tollenaar, Robert A E M ^cf   Seynaeve, Caroline ^cf   Van Asperen, Christi J ^cf   Kristensen, Vessela N ^cf   Australian Ovarian Cancer Study Group, Susan Slager ^cf   Tol, Ama E ^cf   Ambrosone, Christine B ^cf   Yannoukakos, Drakoulis ^cf   Lindblom, Annika ^cf   Margolin, Sara ^cf   Radice, Paolo ^cf   Peterlongo, Paolo ^cf   Barile, Monica ^cf   Mariani, Paolo ^cf   Hooning, Maartje J ^cf   Martens, John W M ^cf   Margriet Collee J ^cf   Jager, Agnes ^cf   Jakubowska, Anna ^cf   Lubinski, Jan ^cf   Jaworska Bieniek, Katarzyna ^cf   Durda, Katarzyna ^cf   Giles, Graham G ^cf   McLean, Catriona ^cf   Brauch, Hiltrud ^cf   Brüning, Thomas ^cf   Ko, Yon Dschun ^cf   The Genica Network, Hermann Brenner ^cf   Dieffenbach, Aida Karina ^cf   Arndt, Volker ^cf   Stegmaier, Christa ^cf   Swerdlow, Anthony ^cf   Ashworth, Alan ^cf   Orr, Nick ^cf   Jones, Michael ^cf   Simard, Jacques ^cf   Goldberg, Mark S ^cf   Labrèche, France ^cf   Dumont, Martine ^cf   Winqvist, Robert ^cf   Pylkäs, Katri ^cf   Jukkola Vuorinen, Arja ^cf   Grip, Mervi ^cf   Kataja, Vesa ^cf   Kosma, Veli Matti ^cf   Hartikainen, Jaana M ^cf   Mannermaa, Arto ^cf   Hamann, Ute ^cf   Chenevix Trench, Georgia ^{c,d,e,h,i,k,l,v,y,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,ba,bb,bc,bd,be,bf,bg,bh,bi,bj,bk,bl,bm,bn,bo,bp,bq,br,bs,bt,bu,bv,bw,bx,by,bz,ca,cb,cc,cd,ce}   Blomqvist, Carl ^f   Aittomäki, Kristiina ^f   Easton, Douglas F ^c   Nevanlinna, Heli ^a   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF HELSINKI   (Finland)

^g GENOME INSTITUTE OF SINGAPORE   (Singapore)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^m LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^r UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^s MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^t INSTITUTE OF EPIDEMIOLOGY   (Germany)

^u NATIONAL CANCER INSTITUTE   (United States)

^v HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^w UNIVERSITY OF SHEFFIELD   (United Kingdom)

^x ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^y UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^z UNIVERSITY OF CALIFORNIA   (United States)

^aa Mental Health Services CPH   (Denmark)

^ab Centro Nacional de Investigaciones Oncológicas   (Spain)

^ac CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^ad HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^ae HOSPITAL MONTE NARANCO   (Spain)

^af UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ag UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ah MAYO CLINIC   (United States)

^ai DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^aj UNIVERSITY OF LEUVEN   (Belgium)

^ak UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^al NATIONAL INSTITUTES OF HEALTH   (United States)

^am CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^an Universites Paris 12 and Paris 6   (France)

^ao UNIVERSITY OF HEIDELBERG   (Germany)

^ap GUY S HOSPITAL   (United Kingdom)

^aq UNIVERSITY OF OXFORD   (United Kingdom)

^ar UNIVERSITY HOSPITAL GALWAY   (Ireland)

^as MOUNT SINAI HOSPITAL   (Canada)

^at UNIVERSITY OF TORONTO   (Canada)

^au UNIVERSITY OF TORONTO   (Canada)

^av ST MICHAEL'S HOSPITAL   (Canada)

^aw HANNOVER MEDICAL SCHOOL   (Germany)

^ax Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^ay UNIVERSITY OF CALIFORNIA   (United States)

^az INSTITUTE OF ONCOLOGY   (Poland)

^ba LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bb ERASMUS MEDICAL CENTER   (Netherlands)

^bc UNIVERSITY OF OSLO   (Norway)

^bd UNIVERSITY OF OSLO   (Norway)

^be OSLO UNIVERSITY HOSPITAL   (Norway)

^bf PETER MACCALLUM CANCER CENTRE   (Australia)

^bg QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bh OHIO STATE UNIVERSITY   (United States)

^bi ROSWELL PARK CANCER INSTITUTE   (United States)

^bj INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^bk NATIONAL CANCER INSTITUTE   (Italy)

^bl FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^bm EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^bn Department of Obstetrics and Gynaecology Hannover Medical School ^*  (Italy)

^bo POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bp MEDICAL UNIVERSITY OF WARSAW   (Poland)

^bq ALFRED HOSPITAL   (Australia)

^br DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^bs UNIVERSITY OF TÜBINGEN   (Germany)

^bt RUHR UNIVERSITY BOCHUM   (Germany)

^bu Johanniter Krankenhaus   (Germany)

^bv UNIVERSITY OF BONN   (Germany)

^bw SAARLAND CANCER REGISTRY   (Germany)

^bx LAVAL UNIVERSITY   (Canada)

^by MCGILL UNIVERSITY   (Canada)

^bz ROYAL VICTORIA HOSPITAL   (Canada)

^ca UNIVERSITÉ DE MONTRÉAL   (Canada)

^cb UNIVERSITY OF OULU   (Finland)

^cc OULU UNIVERSITY HOSPITAL   (Finland)

^cd UNIVERSITY OF EASTERN FINLAND   (Finland)

^ce KUOPIO UNIVERSITY HOSPITAL   (Finland)

^cf Molecular Diagnostics Laboratory IRRP National Centre for Scientific Research Demokritos ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MICRORNA; 3' UNTRANSLATED REGION; ESTROGEN RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ALLELE; APOPTOSIS; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASP8 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DROSHA GENE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HDDC3 GENE; HUMAN; MAJOR CLINICAL STUDY; MUSTN1 GENE; MYCL1 GENE; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; BREAST NEOPLASMS; CASE CONTROL STUDY; CHROMOSOME MAP; GENETICS; METABOLISM;

3' UNTRANSLATED REGIONS; BINDING SITES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN;

EID: 84912002894     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109973     Document Type: Article

References (53)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
3. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, et al. (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44: 312-318.
4. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45: 353-361, 361e351-352.
5. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary micro RN As by the Microprocessor complex. Nature 432: 231-235.
6. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
7. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, et al. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
8. Sosio M, Kloosterman H, Bianchi A, de Vreugd P, Dijkhuizen L, et al. (2004) Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology 150: 95-102.
9. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of posttranscriptional regulation by micro RN As: are the answers in sight? Nat Rev Genet 9: 102-114.
10. Shukla GC, Singh J, Barik S (2011) MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 3: 83-92.
11. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
12. Zhong X, Coukos G, Zhang L (2012) miRNAs in human cancer. Methods Mol Biol 822: 295-306.
13. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of micro RN As. Genome Res 19: 92-105.
14. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in Human Cancer. Adv Exp Med Biol 774: 1-20.
15. Wang X, Chen X, Wang R, Xiao P, Xu Z, et al. (2013) microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep 30: 643-650.
16. Liang Z, Wu H, Xia J, Li Y, Zhang Y, et al. (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79: 817-824.
17. Volinia S, Croce CM (2013) Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A 110: 7413-7417.
18. Guo L, Zhao Y, Yang S, Cai M, Wu Q, et al. (2012) Genome-wide screen for aberrandy expressed miRNAs reveals miRNA profile signature in breast cancer. Mol Biol Rep.
19. (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
20. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29: 579-584.
21. Song F, Zheng H, Liu B, Wei S, Dai H, et al. (2009) An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SETS gene is associated with early age of breast cancer onset. Clin Cancer Res 15: 6292-6300.
22. Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ ovarian cancer risk modifiers injewish high-risk women. Int J Cancer 127: 589-597.
23. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, et al. (2010) Singlenucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70: 2789-2798.
24. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D (2010) Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 38: D640-651.
25. Dite GS, Jenkins MA, Southey MC, HockingJS, Giles GG, et al. (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Nad Cancer Inst 95: 448-457.
26. Fletcher O, Johnson N, Palles C, dos Santos Silva I, McCormack V, et al. (2006) Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J Natl Cancer Inst 98: 1014-1018.
27. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genomewide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
28. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, et al. (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27: 606-609.
29. Flesch-Janys D, S langer T, Mutschelknauss E, Kropp S, Obi N, et al. (2008) Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 123: 933-941.
30. Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, et al. (2011) A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 126: 717-727.
31. Leu M, Humphreys K, Surakka I, Rehnberg E, Muilu J, et al. (2010) NordicDB: a Nordic pool and portal for genome-wide control data. Eur T Hum Genet 18: 1322-1326.
32. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genomewide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
33. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
34. Liang D, Meyer L, Chang DW, Lin J, Pu X, et al. (2010) Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 70: 9765-9776.
35. Ruiz-Ruiz C, Munoz-Pinedo C, Lopez-Rivas A (2000) Interferen-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 60: 5673-5680.
36. Barrett JH, fles MM, Harland M, Taylor JC, Aitken JF, et al. (2011) Genomewide association study identifies three new melanoma susceptibility loci. Nat Genet 43: 1108-1113.
37. de Martino M, Haitel A, Schatzl G, Klingler HC, Klatte T (2013) The CASP8 -652 6N Insertion/Deletion Promoter Polymorphism Is Associated with Renal Cell Carcinoma Risk and Metastasis. J Urol.
38. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, et al. (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39: 352-358.
39. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, et al. (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127: 309-324.
40. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, et al. (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96: 1866-1869.
41. Frank B, Bermejo JL, Hemminki K, Klaes R, Bugert P, et al. (2005) Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 97: 1012; author reply 1012-1013.
42. Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, et al. (2014) Identification and characterization of novel associations in the CASP8/ ALS2CR12 region on chromosome 2 with breast cancer risk. Hum Mol Genet.
43. Sun D, Lee G, Lee JH, Kim HY, Rhee HW, et al. (2010) A metazoan ortholog of SpoT hydrolyzes ppGpp and functions in starvation responses. Nat Struct Mol Biol 17: 1188-1194.
44. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, et al. (2008) Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9: R139.
45. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
46. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
47. Sung H, Lee KM, Choi JY, Han S, Lee JY, et al. (2011) Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat 130: 939-951.
48. Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, et al. (1988) L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol 8: 2668-2673.
49. Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, et al. (2003) Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. Am J Pathol 162: 1603-1610.
50. Xiong F, Wu C, Chang J, Yu D, Xu B, et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 71: 5175-5181.
51. Lombardo F, Komatsu D, Hadjiargyrou M (2004) Molecular cloning and characterization of Mustang, a novel nuclear protein expressed during skeletal development and regeneration. FASEB J 18: 52-61.
52. Kapushesky M, Adamusiak T, Burdett T, Culhane A, Farne A, et al. (2012) Gene Expression Atlas update-a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res 40: D1077-1081.
53. Witkos TM, Koscianska E, Krzyzosiak WJ (2011) Practical Aspects of microRNA Target Prediction. Curr Mol Med 11: 93-109.